Literature DB >> 9663252

Partial hepatectomy accelerates local tumor growth: potential roles of local cytokine activation.

A Picardo1, H M Karpoff, B Ng, J Lee, M F Brennan, Y Fong.   

Abstract

BACKGROUND: Surgical excision of liver tumors represents the only curative treatment for primary and metastatic liver malignancies. It has been suspected that hepatectomy may stimulate growth of microscopic tumors. To determine whether local or systemic factors after hepatectomy are responsible for enhancement of tumor growth, the effects of hepatectomy on the experimental growth of liver or pulmonary tumors were examined.
METHODS: One hour after injection of 10(6) Morris hepatoma cells into either the portal or femoral vein, which produces isolated liver and lung tumors, respectively, animals were randomized to undergo 0%, 30%, or 70% partial hepatectomy (PH).
RESULTS: Animals that underwent portal injection of tumor had significantly increased liver tumor burden after PH (sham, 25 +/- 7 vs PH, 94 +/- 17; p < 0.01), whereas animals that underwent femoral injection had no change in lung tumor burden after PH. PH was associated with significantly increased levels of transforming growth factor-alpha, transforming growth factor-beta, and basic fibroblast growth factor in the liver but not in the lung.
CONCLUSIONS: Changes in liver cytokine-growth factor activation may contribute to enhanced tumor growth in the liver after hepatectomy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9663252

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  38 in total

1.  Living donor liver transplantation does not increase tumor recurrence of hepatocellular carcinoma compared to deceased donor transplantation.

Authors:  Guang-Qin Xiao; Jiu-Lin Song; Shu Shen; Jia-Yin Yang; Lu-Nan Yan
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

Review 2.  Liver regeneration and tumor stimulation--a review of cytokine and angiogenic factors.

Authors:  Christopher Christophi; Nadia Harun; Theodora Fifis
Journal:  J Gastrointest Surg       Date:  2008-01-08       Impact factor: 3.452

Review 3.  Hepatocellular carcinoma--cause, treatment and metastasis.

Authors:  Z Y Tang
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

4.  Living-donor or deceased-donor liver transplantation for hepatic carcinoma: a case-matched comparison.

Authors:  Ping Wan; Jian-Jun Zhang; Qi-Gen Li; Ning Xu; Ming Zhang; Xiao-Song Chen; Long-Zhi Han; Qiang Xia
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

Review 5.  Cytoreduction for colorectal metastases: liver, lung, peritoneum, lymph nodes, bone, brain. When does it palliate, prolong survival, and potentially cure?

Authors:  Camille L Stewart; Susanne Warner; Kaori Ito; Mustafa Raoof; Geena X Wu; Jonathan Kessler; Jae Y Kim; Yuman Fong
Journal:  Curr Probl Surg       Date:  2018-10-04       Impact factor: 1.909

6.  Next generation sequencing of progressive colorectal liver metastases after portal vein embolization.

Authors:  Eve Simoneau; Jarred Chicoine; Sarita Negi; Ayat Salman; Anthoula Lazaris; Mazen Hassanain; Nicole Beauchemin; Stephanie Petrillo; David Valenti; Ramila Amre; Peter Metrakos
Journal:  Clin Exp Metastasis       Date:  2017-07-31       Impact factor: 5.150

7.  Accelerated carcinogenesis following liver resection in chronically inflamed livers: A window of opportunity for treatment.

Authors:  Amir Sonnenblick; Tamar Zahavi
Journal:  Biomed Rep       Date:  2017-03-30

8.  Herbal compound "Songyou Yin" reinforced the ability of interferon-alfa to inhibit the enhanced metastatic potential induced by palliative resection of hepatocellular carcinoma in nude mice.

Authors:  Xiu-Yan Huang; Zi-Li Huang; Lu Wang; Yong-Hua Xu; Xin-Yu Huang; Kai-Xing Ai; Qi Zheng; Zhao-You Tang
Journal:  BMC Cancer       Date:  2010-10-25       Impact factor: 4.430

9.  Preoperative portal vein embolization for extended hepatectomy.

Authors:  Alan W Hemming; Alan I Reed; Richard J Howard; Shiro Fujita; Steven N Hochwald; James G Caridi; Irvin F Hawkins; Jean-Nicolas Vauthey
Journal:  Ann Surg       Date:  2003-05       Impact factor: 12.969

10.  Hepatic resection but not radiofrequency ablation results in tumor growth and increased growth factor expression.

Authors:  Kenneth Meredith; Dieter Haemmerich; Chen Qi; David Mahvi
Journal:  Ann Surg       Date:  2007-05       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.